{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:25:40Z","timestamp":1790267140713,"version":"4.1.0"},"reference-count":103,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>The assessment and treatment of children with growth retardation is increasingly complex, and due to availability of targeted genetic sequencing, an ever-expanding number of conditions impeding growth are being identified. Among endocrine-related etiologies of short stature amenable to hormonal treatment, defects in the growth hormone (GH)\u2013insulin-like growth factor I axis remain pre-eminent, with a multiplicity of disorders causing decreased secretion or insensitivity to GH action. Sex steroids in puberty increase epiphyseal senescence and eventual growth plate closure. This is mediated mostly via estrogen receptor (ER)\u03b1 in males and females, effects that can greatly limit time available for growth.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence Acquisition<\/jats:title>\n                  <jats:p>Extensive literature review through PubMed and other search engines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence Synthesis<\/jats:title>\n                  <jats:p>Therapeutic strategies to be considered in peripubertal and pubertal children with disordered growth are here discussed, including daily and weekly GH, low-dose sex steroids, gonadotropin hormone releasing hormone (GnRH) analogues in combination with GH, aromatase inhibitors (AIs) alone and in combination with GH in boys. When used for at least 2 to 3 years, GnRH analogues combined with GH can result in meaningful increases in height. AIs used with GH permit puberty to progress in boys without hindrance, selectively decreasing estrogen, and resulting in taller height. With more than 20 years of cumulative experience in clinical use of these medications, we discuss the safety profile of these treatments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The approach of growth retardation in the peripubertal and pubertal years must consider the sex steroid milieu and the tempo of bone acceleration. Treatment of affected children in this period must be individualized.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae011","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T23:20:05Z","timestamp":1704496805000},"page":"e1522-e1533","source":"Crossref","is-referenced-by-count":10,"title":["Approach to the Peripubertal Patient With Short Stature"],"prefix":"10.1210","volume":"109","author":[{"given":"Lournaris","family":"Torres-Santiago","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes & Metabolism, Nemours Children\u2019s Health , Jacksonville, FL 32207 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1175-3852","authenticated-orcid":false,"given":"Nelly","family":"Mauras","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes & Metabolism, Nemours Children\u2019s Health , Jacksonville, FL 32207 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"issue":"1","key":"2024061623514528200_dgae011-B1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tem.2003.11.004","article-title":"Activation of the human GH gene cluster: roles for targeted chromatin modification","volume":"15","author":"Ho","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"2024061623514528200_dgae011-B2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ghir.2015.09.004","article-title":"Regulation of skeletal growth and mineral acquisition by the GH\/IGF-1 axis: lessons from mouse models","volume":"28","author":"Yakar","year":"2016","journal-title":"Growth Horm IGF Res"},{"issue":"4","key":"2024061623514528200_dgae011-B3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.15252\/emmm.201506106","article-title":"Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability","volume":"8","author":"Dauber","year":"2016","journal-title":"EMBO Mol Med"},{"key":"2024061623514528200_dgae011-B4","doi-asserted-by":"crossref","first-page":"110967","DOI":"10.1016\/j.mce.2020.110967","article-title":"Disorders caused by genetic defects associated with GH-dependent genes: PAPPA2 defects","volume":"518","author":"Fujimoto","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"2024061623514528200_dgae011-B5","doi-asserted-by":"crossref","first-page":"e71931","DOI":"10.7554\/eLife.71931","article-title":"C-type natriuretic peptide facilitates autonomic Ca2+ entry in growth plate chondrocytes for stimulating bone growth","volume":"11","author":"Miyazaki","year":"2022","journal-title":"Elife"},{"issue":"8","key":"2024061623514528200_dgae011-B6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1507\/endocrj.K10E-164","article-title":"Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias","volume":"57","author":"Yasoda","year":"2010","journal-title":"Endocr J"},{"issue":"1","key":"2024061623514528200_dgae011-B7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJMoa1813446","article-title":"C-type natriuretic peptide analogue therapy in children with achondroplasia","volume":"381","author":"Savarirayan","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"2024061623514528200_dgae011-B8","first-page":"717","article-title":"Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human","volume":"19","author":"Giustina","year":"1998","journal-title":"Endocr Rev"},{"issue":"2","key":"2024061623514528200_dgae011-B9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11102-007-0035-9","article-title":"Normal levels of serum IGF-I: determinants and validity of current reference ranges","volume":"10","author":"Brabant","year":"2007","journal-title":"Pituitary"},{"issue":"3","key":"2024061623514528200_dgae011-B10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem-69-3-563","article-title":"Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys","volume":"69","author":"Martha","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024061623514528200_dgae011-B11","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1210\/jcem-64-3-596","article-title":"Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon","volume":"64","author":"Mauras","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024061623514528200_dgae011-B12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/jcem-62-1-159","article-title":"The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males","volume":"62","author":"Link","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024061623514528200_dgae011-B13","first-page":"513","article-title":"Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence","volume":"79","author":"Metzger","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024061623514528200_dgae011-B14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(85)80501-1","article-title":"Clinical longitudinal standards for height and height velocity for North American children","volume":"107","author":"Tanner","year":"1985","journal-title":"J Pediatr"},{"issue":"1","key":"2024061623514528200_dgae011-B15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1210\/er.2003-0038","article-title":"Endocrine control of body composition in infancy, childhood, and puberty","volume":"26","author":"Veldhuis","year":"2005","journal-title":"Endocr Rev"},{"issue":"1","key":"2024061623514528200_dgae011-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endrev\/bnac014","article-title":"Management of growth disorders in puberty: GH, GnRHa, and aromatase inhibitors: a clinical review","volume":"44","author":"Mauras","year":"2023","journal-title":"Endocr Rev"},{"issue":"16","key":"2024061623514528200_dgae011-B17","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199410203311604","article-title":"Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man [published correction appears in N Engl J Med 1995 Jan 12;332(2):131]","volume":"331","author":"Smith","year":"1994","journal-title":"N Engl J Med"},{"issue":"12","key":"2024061623514528200_dgae011-B18","first-page":"3689","article-title":"Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens","volume":"80","author":"Morishima","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"2024061623514528200_dgae011-B19","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1007\/s00018-013-1317-1","article-title":"The role of estrogen receptor \u03b1 in the regulation of bone and growth plate cartilage","volume":"70","author":"B\u00f6rjesson","year":"2013","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"2024061623514528200_dgae011-B20","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/en.2013-2175","article-title":"Evidence that estrogen hastens epiphyseal fusion and cessation of longitudinal bone growth by irreversibly depleting the number of resting zone progenitor cells in female rabbits","volume":"155","author":"Nilsson","year":"2014","journal-title":"Endocrinology"},{"issue":"4","key":"2024061623514528200_dgae011-B21","first-page":"157","article-title":"Endocrine regulation of the growth plate","volume":"64","author":"Nilsson","year":"2005","journal-title":"Horm Res"},{"issue":"2","key":"2024061623514528200_dgae011-B22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199707103370204","article-title":"Effect of testosterone and estradiol in a man with aromatase deficiency","volume":"337","author":"Carani","year":"1997","journal-title":"N Engl J Med"},{"issue":"4","key":"2024061623514528200_dgae011-B23","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1210\/jc.2005-1693","article-title":"Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone","volume":"91","author":"Vottero","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024061623514528200_dgae011-B24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000358195","article-title":"Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use","volume":"81","author":"Sas","year":"2014","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"2024061623514528200_dgae011-B25","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1210\/jc.2014-3631","article-title":"Evaluation of 451 Danish boys with delayed puberty: diagnostic use of a new puberty nomogram and effects of oral testosterone therapy","volume":"100","author":"Lawaetz","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024061623514528200_dgae011-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/ENDO:16:1:01","article-title":"Testosterone stimulates growth of tibial epiphyseal growth plate and insulin-like growth factor-1 receptor abundance in hypophysectomized and castrated rats","volume":"16","author":"Phillip","year":"2001","journal-title":"Endocrine"},{"issue":"Suppl 423","key":"2024061623514528200_dgae011-B27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1651-2227.1997.tb18366.x","article-title":"The dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene","volume":"86","author":"Baumann","year":"1997","journal-title":"Acta Paediatr Suppl"},{"issue":"1","key":"2024061623514528200_dgae011-B28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11154-020-09591-4","article-title":"Disruption of the GHRH receptor and its impact on children and adults: the Itabaianinha syndrome","volume":"22","author":"Aguiar-Oliveira","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"issue":"12","key":"2024061623514528200_dgae011-B29","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4158\/EP15939.RA","article-title":"Lessons from 50 years of study of Laron syndrome","volume":"21","author":"Laron","year":"2015","journal-title":"Endocr Pract"},{"issue":"18","key":"2024061623514528200_dgae011-B30","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJM199610313351805","article-title":"Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene","volume":"335","author":"Woods","year":"1996","journal-title":"N Engl J Med"},{"issue":"12","key":"2024061623514528200_dgae011-B31","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa022926","article-title":"Growth hormone insensitivity associated with a STAT5b mutation","volume":"349","author":"Kofoed","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"2024061623514528200_dgae011-B32","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa013100","article-title":"Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene","volume":"350","author":"Domen\u00e9","year":"2004","journal-title":"N Engl J Med"},{"issue":"23","key":"2024061623514528200_dgae011-B33","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa010107","article-title":"IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation","volume":"349","author":"Abuzzahab","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"2024061623514528200_dgae011-B34","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0430","article-title":"Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting","volume":"177","author":"Gravholt","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2024061623514528200_dgae011-B35","doi-asserted-by":"crossref","first-page":"1011960","DOI":"10.3389\/fendo.2022.1011960","article-title":"Genetic conditions of short stature: a review of three classic examples","volume":"13","author":"Butler","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2024061623514528200_dgae011-B36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1515\/JPEM.2005.18.2.171","article-title":"Constitutional delay of growth and puberty: from presentation to final height","volume":"18","author":"Poyrazo\u011flu","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"2024061623514528200_dgae011-B37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/BF02079065","article-title":"Final height and predicted height in boys with untreated constitutional growth delay","volume":"154","author":"Sperlich","year":"1995","journal-title":"Eur J Pediatr"},{"issue":"9","key":"2024061623514528200_dgae011-B38","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJM199202273260904","article-title":"Osteopenia in men with a history of delayed puberty","volume":"326","author":"Finkelstein","year":"1992","journal-title":"N Engl J Med"},{"issue":"9","key":"2024061623514528200_dgae011-B39","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1210\/jc.2004-0046","article-title":"The skeletal phenotype of men with previous constitutional delay of puberty","volume":"89","author":"Yap","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024061623514528200_dgae011-B40","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1172\/JCI117049","article-title":"Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone","volume":"93","author":"Mauras","year":"1994","journal-title":"J Clin Invest"},{"issue":"4","key":"2024061623514528200_dgae011-B41","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jcem.87.4.8395","article-title":"Delayed puberty: analysis of a large case series from an academic center","volume":"87","author":"Sedlmeyer","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024061623514528200_dgae011-B42","first-page":"296","article-title":"Body weight progression and nutritional status of patients with familial short stature with and without constitutional delay in growth [published correction appears in Am J Dis Child 1993 Jun;147(6):609]","volume":"146","author":"Solans","year":"1992","journal-title":"Am J Dis Child"},{"issue":"1","key":"2024061623514528200_dgae011-B43","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1542\/peds.2004-1684","article-title":"Children with idiopathic short stature are poor eaters and have decreased body mass index","volume":"116","author":"Wudy","year":"2005","journal-title":"Pediatrics"},{"issue":"3","key":"2024061623514528200_dgae011-B44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/ajcn\/36.3.527","article-title":"The effect of chronic childhood malnutrition on pubertal growth and development","volume":"36","author":"Kulin","year":"1982","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2024061623514528200_dgae011-B45","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1203\/00006450-198506000-00003","article-title":"A follow-up study of the effects of early malnutrition on subsequent development. I. Physical growth and sexual maturation during adolescence","volume":"19","author":"Galler","year":"1985","journal-title":"Pediatr Res"},{"issue":"2","key":"2024061623514528200_dgae011-B46","doi-asserted-by":"crossref","first-page":"521S","DOI":"10.1093\/ajcn\/72.2.521S","article-title":"Growth and pubertal development in children and adolescents: effects of diet and physical activity","volume":"72","author":"Rogol","year":"2000","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2024061623514528200_dgae011-B47","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1210\/jc.2005-2762","article-title":"Evidence for hypermetabolism in boys with constitutional delay of growth and maturation","volume":"91","author":"Han","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"9270","key":"2024061623514528200_dgae011-B48","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0140-6736(00)04895-9","article-title":"A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial","volume":"357","author":"Wickman","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"2024061623514528200_dgae011-B49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jpeds.2010.09.006","article-title":"Effects of growth hormone and nutritional therapy in boys with constitutional growth delay: a randomized controlled trial","volume":"158","author":"Han","year":"2011","journal-title":"J Pediatr"},{"issue":"1","key":"2024061623514528200_dgae011-B50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000502231","article-title":"Diagnosis, genetics, and therapy of short stature in children: a Growth Hormone Research Society international perspective","volume":"92","author":"Collett-Solberg","year":"2019","journal-title":"Horm Res Paediatr"},{"issue":"7","key":"2024061623514528200_dgae011-B51","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S2213-8587(18)30034-2","article-title":"A genetic approach to evaluation of short stature of undetermined cause","volume":"6","author":"Murray","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2024061623514528200_dgae011-B52","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1210\/jc.2016-3313","article-title":"Clinical characterization of patients with autosomal dominant short stature due to aggrecan mutations","volume":"102","author":"Gkourogianni","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024061623514528200_dgae011-B53","doi-asserted-by":"crossref","first-page":"E1510","DOI":"10.1210\/jc.2014-1332","article-title":"Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations","volume":"99","author":"Nilsson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024061623514528200_dgae011-B54","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1210\/jc.2017-02026","article-title":"IHH gene mutations causing short stature with nonspecific skeletal abnormalities and response to growth hormone therapy","volume":"103","author":"Vasques","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024061623514528200_dgae011-B55","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ng.3097","article-title":"Defining the role of common variation in the genomic and biological architecture of adult human height","volume":"46","author":"Wood","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"2024061623514528200_dgae011-B56","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/gim.2017.159","article-title":"Clinical relevance of systematic phenotyping and exome sequencing in patients with short stature","volume":"20","author":"Hauer","year":"2018","journal-title":"Genet Med"},{"issue":"2","key":"2024061623514528200_dgae011-B57","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/cen.12867","article-title":"Higher methylation of the IGF1 P2 promoter is associated with idiopathic short stature","volume":"84","author":"Ouni","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"16","key":"2024061623514528200_dgae011-B58","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM199910143411607","article-title":"Growth hormone therapy in adults and children","volume":"341","author":"Vance","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"2024061623514528200_dgae011-B59","first-page":"240","article-title":"National cooperative growth study: 25 years of growth hormone data, insights, and lessons for future registries","volume":"16","author":"Bell","year":"2018","journal-title":"Pediatr Endocrinol Rev"},{"issue":"7","key":"2024061623514528200_dgae011-B60","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1210\/jc.2005-0208","article-title":"Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial","volume":"90","author":"Mauras","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024061623514528200_dgae011-B61","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/clinem\/dgab928","article-title":"Effective GH replacement with once-weekly somapacitan vs daily GH in children with GHD: 3-year results from REAL 3","volume":"107","author":"S\u00e4vendahl","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024061623514528200_dgae011-B62","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1210\/clinem\/dgab529","article-title":"Weekly lonapegsomatropin in treatment-na\u00efve children with growth hormone deficiency: the phase 3 heiGHt trial","volume":"106","author":"Thornton","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024061623514528200_dgae011-B63","doi-asserted-by":"crossref","first-page":"e2680","DOI":"10.1210\/clinem\/dgac217","article-title":"Safety and efficacy of lonapegsomatropin in children with growth hormone deficiency: enliGHten trial 2-year results","volume":"107","author":"Maniatis","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024061623514528200_dgae011-B64","doi-asserted-by":"crossref","first-page":"e2717","DOI":"10.1210\/clinem\/dgac220","article-title":"Efficacy and safety of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: a phase 3 study","volume":"107","author":"Deal","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024061623514528200_dgae011-B65","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1515\/jpem-2022-0359","article-title":"An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment","volume":"36","author":"Zadik","year":"2023","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2024061623514528200_dgae011-B66","doi-asserted-by":"crossref","first-page":"106805","DOI":"10.1016\/j.phrs.2023.106805","article-title":"Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: a systematic review and meta-analysis","volume":"193","author":"Mameli","year":"2023","journal-title":"Pharmacol Res"},{"issue":"6","key":"2024061623514528200_dgae011-B67","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1159\/000523791","article-title":"Long-acting growth hormone preparations and their use in children with growth hormone deficiency [published online ahead of print, 2022 Feb 25]","volume":"96","author":"Pampanini","year":"2023","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"2024061623514528200_dgae011-B68","doi-asserted-by":"crossref","first-page":"601","DOI":"10.20945\/2359-3997000000190","article-title":"Perspectives on long-acting growth hormone therapy in children and adults","volume":"63","author":"Lal","year":"2020","journal-title":"Arch Endocrinol Metab"},{"issue":"6","key":"2024061623514528200_dgae011-B69","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency","volume":"86","author":"Grimberg","year":"2016","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"2024061623514528200_dgae011-B70","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1203\/00006450-199012000-00018","article-title":"Increased hGH production rate after low-dose estrogen therapy in prepubertal girls with Turner\u2019s syndrome","volume":"28","author":"Mauras","year":"1990","journal-title":"Pediatr Res"},{"issue":"13","key":"2024061623514528200_dgae011-B71","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1005669","article-title":"Growth hormone plus childhood low-dose estrogen in Turner\u2019s syndrome","volume":"364","author":"Ross","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"2024061623514528200_dgae011-B72","first-page":"569","article-title":"Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial","volume":"85","author":"Mericq","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024061623514528200_dgae011-B73","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1210\/jc.2012-1987","article-title":"Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial","volume":"97","author":"Lem","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024061623514528200_dgae011-B74","first-page":"2969","article-title":"A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation","volume":"86","author":"Kamp","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024061623514528200_dgae011-B75","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/jc.2009-1577","article-title":"Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency","volume":"95","author":"Scalco","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024061623514528200_dgae011-B76","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1515\/JPEM.2003.16.7.1005","article-title":"Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution","volume":"16","author":"Pucarelli","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"12","key":"2024061623514528200_dgae011-B77","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1210\/jc.2005-1392","article-title":"Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial","volume":"90","author":"Hero","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024061623514528200_dgae011-B78","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/jc.2007-1559","article-title":"Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years","volume":"93","author":"Mauras","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2024061623514528200_dgae011-B79","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1210\/jc.2016-2891","article-title":"Randomized trial of aromatase inhibitors, growth hormone, or combination in pubertal boys with idiopathic, short stature","volume":"101","author":"Mauras","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024061623514528200_dgae011-B80","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1687-9856-2015-4","article-title":"A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature [published correction appears in Int J Pediatr Endocrinol. 2017;2017:4]","volume":"2015","author":"Rothenbuhler","year":"2015","journal-title":"Int J Pediatr Endocrinol"},{"issue":"1","key":"2024061623514528200_dgae011-B81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13633-020-00089-z","article-title":"Height outcomes in children with growth hormone deficiency and idiopathic short stature treated concomitantly with growth hormone and aromatase inhibitor therapy: data from the ANSWER program","volume":"2020","author":"Miller","year":"2020","journal-title":"Int J Pediatr Endocrinol"},{"issue":"6","key":"2024061623514528200_dgae011-B82","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000315482","article-title":"A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature","volume":"74","author":"Salehpour","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"2024061623514528200_dgae011-B83","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpeds.2017.07.047","article-title":"Effect of antiandrogen, aromatase inhibitor, and gonadotropin-releasing hormone analog on adult height in familial male precocious puberty","volume":"190","author":"Leschek","year":"2017","journal-title":"J Pediatr"},{"issue":"4","key":"2024061623514528200_dgae011-B84","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40618-015-0399-z","article-title":"Anastrozole plus leuprorelin in early maturing girls with compromised growth: the \u201cGAIL\u201d study","volume":"39","author":"Papadimitriou","year":"2016","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2024061623514528200_dgae011-B85","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000501336","article-title":"Use of gonadotropin-releasing hormone analogs in children: update by an International Consortium","volume":"91","author":"Bangalore Krishna","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"2024061623514528200_dgae011-B86","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000084097","article-title":"Gonadotropin-releasing hormone analogue treatment for precocious puberty. Twenty years of experience","volume":"8","author":"Heger","year":"2005","journal-title":"Endocr Dev"},{"issue":"2","key":"2024061623514528200_dgae011-B87","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/17446651.2019.1575726","article-title":"Update on central precocious puberty: from etiologies to outcomes","volume":"14","author":"Cantas-Orsdemir","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"4","key":"2024061623514528200_dgae011-B88","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1210\/jc.2006-2272","article-title":"Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty","volume":"92","author":"van Gool","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2024061623514528200_dgae011-B89","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1530\/eje.0.151s047","article-title":"Bone development during GH and GnRH analog treatment","volume":"151","author":"Antoniazzi","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2024061623514528200_dgae011-B90","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1651-2227.2001.tb01349.x","article-title":"Psychological assessments before and after treatment of early puberty in adopted children","volume":"90","author":"Mul","year":"2001","journal-title":"Acta Paediatr"},{"issue":"11","key":"2024061623514528200_dgae011-B91","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1210\/jc.2018-01463","article-title":"Cognition, health-related quality of life, and psychosocial functioning after GH\/GnRHa treatment in young adults born SGA","volume":"103","author":"Goedegebuure","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024061623514528200_dgae011-B92","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa013555","article-title":"Treatment with a Luteinizing Hormone\u2013Releasing Hormone Agonist in Adolescents with Short Stature","volume":"348","author":"Yanovski","year":"2003","journal-title":"N Engl J Med"},{"issue":"8","key":"2024061623514528200_dgae011-B93","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/bjc.1996.531","article-title":"Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer","volume":"74","author":"Geisler","year":"1996","journal-title":"Br J Cancer"},{"issue":"3","key":"2024061623514528200_dgae011-B94","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.2002.20.3.751","article-title":"Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study","volume":"20","author":"Geisler","year":"2002","journal-title":"J Clin Oncol"},{"issue":"9","key":"2024061623514528200_dgae011-B95","first-page":"2089","article-title":"In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients","volume":"4","author":"Geisler","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2024061623514528200_dgae011-B96","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/annonc\/mdq337","article-title":"The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum","volume":"22","author":"L\u00f8nning","year":"2011","journal-title":"Ann Oncol"},{"issue":"8","key":"2024061623514528200_dgae011-B97","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/jc.2008-2527","article-title":"Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia","volume":"94","author":"Mauras","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2024061623514528200_dgae011-B98","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1210\/jc.2003-031279","article-title":"Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males [published correction appears in J Clin Endocrinol Metab. 2004 Feb;89(2):732]","volume":"88","author":"Mauras","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024061623514528200_dgae011-B99","first-page":"2370","article-title":"Estrogen suppression in males: metabolic effects","volume":"85","author":"Mauras","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2024061623514528200_dgae011-B100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fendo.2019.00201","article-title":"Letrozole monotherapy in pre- and early-pubertal boys does not increase adult height","volume":"10","author":"Varimo","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2024061623514528200_dgae011-B101","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000496353","article-title":"Quality of life in adolescent boys with idiopathic short stature: positive impact of growth hormone and aromatase inhibitors","volume":"90","author":"Bullinger","year":"2018","journal-title":"Horm Res Paediatr"},{"issue":"30","key":"2024061623514528200_dgae011-B102","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2201067119","article-title":"A long-acting C-natriuretic peptide for achondroplasia","volume":"119","author":"Schneider","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2024061623514528200_dgae011-B103","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1542\/peds.2013-4060","article-title":"Off-label use of drugs in children","volume":"133","author":"Frattarelli","year":"2014","journal-title":"Pediatrics"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae011\/56167702\/dgae011.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/7\/e1522\/58235385\/dgae011.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/7\/e1522\/58235385\/dgae011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T23:52:42Z","timestamp":1718581962000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/7\/e1522\/7512031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":103,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,1,5]]},"published-print":{"date-parts":[[2024,6,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae011","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,1,5]]}}}